Farshad Banouei | Oncology Case Reports | Excellence in Innovation

Excellence in Innovation

Farshad Banouei
Hasheminjad Kidney Center, School of Medicine, Iran

Farshad Banouei

Affiliation Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences
Country Iran
Scopus ID 58574525400
Documents 5
Citation 2
h-index 1
Subject Area Oncology Case Reports
Event International Research Awards on Oncology and Cancer Research

Farshad Banouei is a researcher affiliated with Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research recognition profile titled Excellence in Innovation highlights the importance of scientific contributions, interdisciplinary research, and innovation in advancing medical knowledge. The supplied publication records cover subjects including biomaterials, laser-based treatment approaches, dermatological interventions, nanomaterials, and clinical treatment research.

Abstract

Scientific innovation in medicine involves the development and evaluation of new materials, therapeutic techniques, diagnostic approaches, and clinical interventions. The supplied publication records associated with this research profile represent several areas of biomedical investigation, including hydrogel-based tissue expansion, laser-assisted treatment, photodynamic therapy, nanocrystal synthesis, and clinical management of medical conditions. These subjects demonstrate the interdisciplinary nature of contemporary biomedical research and the importance of collaboration across clinical medicine, materials science, and healthcare technology.

Keywords

Oncology Case Reports, Biomedical Research, Medical Innovation, Clinical Research, Laser Therapy, Photodynamic Therapy, Biomaterials, Hydrogel Polymers, Nanocrystals, Tissue Engineering, Cancer Research, Dermatological Treatment, Medical Materials Science, Therapeutic Development, Translational Medicine.

Introduction

Medical research continues to evolve through the integration of clinical knowledge, advanced materials, and innovative therapeutic technologies. Developments in biomaterials and tissue engineering contribute to the investigation of materials suitable for medical applications, while laser-based treatment methods provide additional approaches for managing selected clinical conditions. Similarly, nanomaterial research expands opportunities for investigating materials with specialized physical and chemical properties.

Research Profile

Farshad Banouei is presented in this recognition profile with an institutional affiliation at Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research subject area identified for the profile is Oncology Case Reports. The supplied publication information provides a broader multidisciplinary scientific context, including biomaterials, clinical treatment procedures, laser applications, and nanomaterial synthesis.

Research Contributions

  • Biomaterials and tissue engineering: Research on methacrylate-based hydrogel polymers examines materials developed for tissue expansion applications in stomatology, contributing to the broader investigation of polymer-based medical materials.[1]
  • Clinical treatment research: Publications addressing infantile hemangiomas describe treatment procedures and clinical management considerations for a vascular condition encountered in pediatric medicine.[2]

Publications

The following selected bibliographic records were supplied for this academic profile. They are presented with their available journal, year, DOI, and contributor information. The records should not be interpreted as independently verified publications authored by Farshad Banouei, since the supplied contributor lists do not include that name.

  1. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers.
  2. Infantile hemangiomas. Current treatment procedures | Infantilní hemangiomas. Současné tělečné protředky.
  3. Direct and indirect treatment of pain with lasers – Update 2016.

Research Impact

The supplied publications address research questions across several areas of biomedical science. Work on hydrogel polymers contributes to the scientific literature on biomaterials and their potential applications in tissue-related procedures. Investigations into laser-assisted treatment and photodynamic therapy provide clinical perspectives on therapeutic techniques, including approaches studied in dermatology and pain management. Nanocrystal synthesis research contributes to materials chemistry and the development of specialized nanoscale materials.

Award Suitability

The Excellence in Innovation recognition theme under the International Research Awards on Oncology and Cancer Research highlights scientific originality, research development, and contributions that may support progress in medical and biomedical disciplines.The multidisciplinary subjects represented in the supplied publication records offer potential areas for evaluating innovation in clinical treatment, biomedical materials, and therapeutic research. Relevant evaluation considerations may include:.

Conclusion

Excellence in medical innovation depends on sustained scientific investigation, interdisciplinary collaboration, and the translation of research findings into meaningful biomedical applications. The supplied publication records demonstrate the breadth of topics represented in contemporary biomedical and clinical literature, ranging from hydrogel-based materials and nanocrystal synthesis to laser-assisted therapies and photodynamic treatment.

References

  1. Google scholar profile. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers. Journal of Materials Science: Materials in Medicine.
    https://scholar.google.com/citations?user=topjvN4AAAAJ&hl=en
  2. Šmucler, R., & Jenčová, J. (2016). Direct and indirect treatment of pain with lasers – Update 2016. Disease.
    Scopus
    https://www.scopus.com/authid/detail.uri?authorId=58574525400
  3. Bartůněk, V., Rak, J., Pelánková, B., Junková, J., Mezlíková, M., Král, V., Kuchař, M., Engstová, H., Ježek, P., & Šmucler, R. (2016). Large scale preparation of up-converting YF3:YbEr nanocrystals with various sizes by solvothermal syntheses using ionic liquid bmimCl. Journal of Fluorine Chemistry.
    https://doi.org/10.1016/j.jfluchem.2016.05.015
  4. Lippert, J., Šmucler, R., & Vlk, M. (2013). Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatologic Surgery.
    https://doi.org/10.1111/dsu.12242

Luis Rico | Oncology | Editorial Board Member

Dr. Luis Rico | Oncology | Editorial Board Member

Managing Director | Hospital Aleman | Argentina

Dr. Luis Rico is a distinguished clinician–researcher at Hospital Alemán, Buenos Aires, renowned for his impactful contributions to urology, with a strong focus on endourology, advanced laser technologies, and minimally invasive surgical innovation. His work centers on improving procedural precision, optimizing perioperative outcomes, and enhancing patient safety in the management of complex urolithiasis. By integrating next-generation laser systems, cutting-edge endoscopic platforms, and refined surgical protocols, Dr. Rico continually advances evidence-based approaches that elevate standards of clinical care. With an active and growing academic footprint, he has authored numerous peer-reviewed publications addressing pivotal challenges in intrarenal surgery, flexible ureteroscopy, and comparative laser performance particularly evaluating modalities such as the Thulium Fiber Laser and HO:YAG systems. His research has expanded global understanding of operative efficiency, stone-free rates, laser–tissue dynamics, and postoperative recovery pathways. Dr. Rico collaborates extensively with international urology organizations, multidisciplinary surgical teams, and multicenter research networks, underscoring his commitment to shared scientific progress, surgical innovation, and clinical excellence. In addition to his research, he plays a key role in clinical training, contributes to multicenter trials, and advances patient-centered care through methodical, outcomes-driven practice. His scholarly contributions reflect a balanced blend of innovation, scientific rigor, and translational relevance, ensuring continued impact on the evolving landscape of urologic surgery and minimally invasive therapeutic strategies. Dr. Rico’s academic influence is further highlighted by his research metrics, which include 252 citations, 35 scientific documents, and an h-index of 9, reflecting both the quality and reach of his contributions to modern urological science.

Featured Publications

Rico, L., Blas, L., Álvarez Jaramillo, J., Filgueira, G., Soldano, J., & Contreras, P. (2025). Magneto Ho:YAG laser versus Thulium Fiber Laser for laser lithotripsy during flexible ureteroscopy with a flexible and navigable ureteral access sheath. International Urology and Nephrology.

Rico, L., Blas, L., Banda Ramos, L., Maqueda, M., Pizzarello, J., & Contreras, P. (2025). Thulium Fiber Laser versus Vapor Tunnel HO:YAG laser in retrograde intrarenal surgery: Which one has better laser ablation performance? World Journal of Urology.

Rico, L., Diaz-Zorita, V., Blas, L., Banda Ramos, L., Sabeh, P., & Contreras, P. (2025). Is the ablation stone efficacy and efficiency better with a flexible and navigable suction ureteric access sheath? World Journal of Urology.

Rico, L., Blas, L., Pizzarello, J., Banda-Ramos, L., & Contreras, P. (2024). Mini-endoscopic combined intrarenal surgery (mini-ECIRS) for complex urolithiasis. World Journal of Urology.

Rico, L., Maqueda, M., Blas, L., & Contreras, P. (2024). Anterograde placement of drug-coated balloon for ureteroileal anastomosis stricture. BMJ Case Reports.

Shahanavaj Khan | Cancer Science | Editorial Board Member

Assoc. Prof. Dr. Shahanavaj Khan | Cancer Science | Editorial Board Member

Associate Professor | Shri Ram College | India

Dr. Shahanavaj Khan is a distinguished researcher at King Saud University, Riyadh, specializing in cancer biology, pharmacology, and bioactive natural compounds. His work focuses on the anti-cancer and anti-inflammatory potential of plant-derived molecules, with particular emphasis on mechanisms involving apoptosis, Toll-Like Receptors, and microbiome-mediated cancer pathways. Dr. Khan employs advanced in-silico, in-vitro, and translational approaches to identify novel therapeutic targets and understand disease mechanisms, aiming to improve cancer diagnostics and treatment strategies. He has authored 54 publications in high-impact journals, contributing significantly to the understanding of prostate, lung, and other cancers, while integrating computational modeling with experimental validation. His research involves extensive collaborations with over 200 co-authors globally, demonstrating leadership in multidisciplinary oncology and pharmacology networks. Through his innovative studies on natural bioactive compounds and cancer therapeutics, Dr. Khan has contributed to the advancement of safer, more targeted treatment options, positively impacting patient care and public health. His scholarly work also underscores the importance of microbiome and receptor-mediated mechanisms in disease progression, bridging fundamental research with clinical applications. Dr. Khan’s academic influence and research productivity are reflected in his metrics 1,355 citations, 54 documents, and an h-index of 21.

Profiles: Scopus

Featured Publications

Khan, S., et al. (2025). Implication of Toll-Like Receptors in growth and management of health and diseases: Special focus as a promising druggable target to Prostate Cancer. [Review]. 7 citations.

Khan, S., et al. (2025). The implication of microbiome in lungs cancer: mechanisms and strategies of cancer growth, diagnosis and therapy. [Review]. 6 citations.

Khan, S., et al. (2025). Analysis of anti-cancer and anti-inflammatory activity in Typhonium flagelliforme rhizome extract by induction of apoptosis: An in-vitro study. Fitoterapia.

Oncologists – Types and roles

Oncologists – Types and roles

 

Introduction to Oncologists – Types and Roles: Oncologists are medical professionals who specialize in the diagnosis, treatment, and management of cancer. Within the field of oncology, there are various types of oncologists, each with distinct roles and responsibilities tailored to different aspects of cancer care. Understanding these specialized roles is essential for providing comprehensive and effective cancer treatment. Here are five key types and roles of oncologists:

Medical Oncologists: Medical oncologists are primarily responsible for the overall management of cancer patients. They specialize in systemic treatments such as chemotherapy, targeted therapy, and immunotherapy, and they work closely with patients to develop personalized treatment plans.

Surgical Oncologists: Surgical oncologists are experts in performing surgical procedures to remove cancerous tumors or tissue. Their role involves precise and often complex surgeries aimed at treating or staging cancer.

Radiation Oncologists: Radiation oncologists specialize in the use of radiation therapy to target and destroy cancer cells. They design and oversee radiation treatment plans and ensure its safe and effective delivery to patients.

Pediatric Oncologists: Pediatric oncologists specialize in the diagnosis and treatment of cancer in children and adolescents. They have a deep understanding of the unique needs of young patients and their families, and they employ specialized treatments tailored to this demographic.

Gynecologic Oncologists: Gynecologic oncologists focus on cancers of the female reproductive system, such as ovarian, uterine, and cervical cancers. They are skilled in surgical and medical interventions specific to gynecological malignancies.

These diverse types of oncologists work collaboratively in multidisciplinary teams to provide comprehensive cancer care, ensuring that patients receive the most appropriate and effective treatments based on their specific cancer type and stage. Their expertise and roles are crucial in the fight against cancer and the improvement of patient outcomes

Oncology and its specialties

 Oncology and its specialties

Introduction to Oncologists – Types and Roles: Oncologists are medical professionals who specialize in the diagnosis, treatment, and management of cancer. Within the field of oncology, there are various types of oncologists, each with distinct roles and responsibilities tailored to different aspects of cancer care. Understanding these specialized roles is essential for providing comprehensive and effective cancer treatment. Here are five key types and roles of oncologists:

Medical Oncologists: Medical oncologists are primarily responsible for the overall management of cancer patients. They specialize in systemic treatments such as chemotherapy, targeted therapy, and immunotherapy, and they work closely with patients to develop personalized treatment plans.

Surgical Oncologists: Surgical oncologists are experts in performing surgical procedures to remove cancerous tumors or tissue. Their role involves precise and often complex surgeries aimed at treating or staging cancer.

Radiation Oncologists: Radiation oncologists specialize in the use of radiation therapy to target and destroy cancer cells. They design and oversee radiation treatment plans and ensure its safe and effective delivery to patients.

Pediatric Oncologists: Pediatric oncologists specialize in the diagnosis and treatment of cancer in children and adolescents. They have a deep understanding of the unique needs of young patients and their families, and they employ specialized treatments tailored to this demographic.

Gynecologic Oncologists: Gynecologic oncologists focus on cancers of the female reproductive system, such as ovarian, uterine, and cervical cancers. They are skilled in surgical and medical interventions specific to gynecological malignancies.

These diverse types of oncologists work collaboratively in multidisciplinary teams to provide comprehensive cancer care, ensuring that patients receive the most appropriate and effective treatments based on their specific cancer type and stage. Their expertise and roles are crucial in the fight against cancer and the improvement of patient outcomes.